Latest filing published 18 Aug 2026 for Tandem Diabetes Care INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Elizabeth Anne Gasser in Tandem Diabetes Care Inc, where the filings describe the role as senior executive. Over a trading history stretching from 27 August 2021 to 15 August 2026, the count stands at 41 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 18 August 2026: an option exercise, in Tandem Diabetes Care Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations